Evaluating the connection between cardiometabolic disorders and the likelihood of aggressive prostate cancer: a systematic review and meta-analysis - Top-Institutions - MDSpire

Evaluating the connection between cardiometabolic disorders and the likelihood of aggressive prostate cancer: a systematic review and meta-analysis

  • By

  • Aurmin J. Amirmokri

  • Christopher A. Loffredo

  • Kepher H. Makambi

  • Nancy A. Dawson

  • October 25, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Cancer Epidemiology
    • Translational Medicine

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Urology
    • Oncology
    • Epidemiology

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Oncology
    • Endocrinology
    • Population Health

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oncology
    • Endocrinology
    • Clinical Research

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Cancer Epidemiology
    • Metabolic Disease

Original Source(s)

Evaluating the connection between cardiometabolic disorders and the likelihood of aggressive prostate cancer: a systematic review and meta-analysis

  • by Aurmin J. Amirmokri, Christopher A. Loffredo, Kepher H. Makambi, Nancy A. Dawson

  • October 25, 2025

Related Content

Trends in obesity-related cardiovascular and cancer mortality in Switzerland 1995-2019: an analysis of multiple causes of death

Beyond the tumor: the role of the gut microbiome in triple-negative breast cancer

Minimally invasive vs. open hepatectomy in patients with obesity and liver tumors: a systematic review and meta-analysis